Posted: 2014-03-24

Click here for the original story at VCHRI's website.

Four researchers from Vancouver Prostate Centre are recipients of Prostate Cancer Research Awards from the U.S. Department of Defense’s Congressionally Directed Medical Research Programs. The awards total more than $2.8 million US.   

Posted: 2014-01-27

A groundbreaking discovery by researchers at The Vancouver Prostate Centre (VPC), a Vancouver Coastal Health Research Institute (VCHRI) centre, is giving scientists unprecedented levels of accuracy in seeing how patient-specific prostate (tumors) respond to drug therapies or develop drug resistance.

Posted: 2014-01-23

VANCOUVER – Today the Canadian Institutes of Health Research (CIHR) is announcing it will match funding from BRI Biopharmaceutical Research Inc (BRI) for a total of $750,000 over a three year Industry Partnered Collaborative Research Grant. This money will enable ongoing research collaborations between Dr. Yuzhuo Wang’s laboratories at the BC Cancer Agency and Vancouver Prostate Centre (VPC), and BRI to develop new state-of-the-art experimental cancer models.

Posted: 2014-01-09

The Michael Smith Foundation for Health Research (MSFHR) and the Vancouver Coastal Research Institute are pleased to present a lecture by one of British Columbia’s most innovative scientists — a man who has bridged the gap between clinical research and new commercial treatments for disease.

Posted: 2014-01-06

Dr. Kim Chi is one of two recipients of the BC Cancer Agency Clinician Researcher Award, funded by BC Cancer Foundation donors. 

Dr. Kim Chi

Selected by their peers from a high calibre of applicants, Dr. Chi and Dr. David W. Scott were awarded a cumulative $1.5 million over five years. Dr. Chi's project will focus on translational research in prostate cancer, while Dr. Scott will further investigate treatment failure in B cell lymphoid cancers.

Posted: 2013-11-18

The groundbreaking computer-aided drug design work of Dr. Artem Cherkasov is featured in MONTECRISTO, Vancouver's quarterly lifestyle magazine. Read the article here.  Additionally, Dr. Ralph Buttyan discussed Movember and prostate cancer research in an article available here.

Posted: 2013-10-15

Dr. Martin Gleave, executive director of the Vancouver Prostate Centre, is the winner of the fourth annual Aubrey J. Tingle Prize. Created in honour of Michael Smith Foundation for Health Research’s founding president and CEO, this award is given to a British Columbia researcher whose work in health research is internationally recognized and has significant impact on advancing clinical or health services and policy research.

Posted: 2013-09-23

The Canadian Cancer Survivor Network today published the results of a Prostate Cancer Quality of Life Patient and Caregiver Survey.  This survey was conducted between June 21 and July 7, 2013, by Leger Marketing on behalf of Janssen Inc., and in partnership with the Canadian Cancer Survivor Network (CCSN), a national network working together by taking action to promote the very best standard of care, support, follow up and quality of life for cancer patients and survivors, and...

Posted: 2013-09-18

The National Cancer Institute, a branch of the National Institutes of Health, has awarded an $11.3 million, five-year competitive grant renewal to the Pacific Northwest Prostate Cancer Specialized Programs of Research Excellence (SPORE).

Drs. Martin Gleave and Christopher Ong of the Vancouver Prostate Centre are co-leaders of one of five projects awarded funding in this grant.

Posted: 2013-06-21

Prostate Cancer Canada has annouced the recipients of the initial Movember Discovery Grants.  Fourty grants were awarded in total from a record 154 applications.  The grants are funded for two years to a maximum of $200,000 each. 

Drs. Cherkasov, Collins, Dong and Goldenberg lead four of the successfully funded projects, and VPC scientists are co-investigators on two others.

A World Class Centre

The Vancouver Prostate Centre (VPC) has a track record of success that has earned it a reputation as one of the world’s most respected cancer facilities. It is a National Centre of Excellence and a designated Centre of Excellence for Commercialization and Research.


Work at the Vancouver Prostate Centre

Thursday, January 18, 2018

Discovery of a promising new medication to block "master key" of cancer growth

Dr. Chris Ong
Tuesday, February 20, 2018

Drs. Wyatt and Chi: ctDNA predicts resistance to AR-targeted therapy

VCHRI News article on study of ctDNA predicting resistance to AR-targeted therapy

Make A Difference

Help the Vancouver Prostate Centre fund research to find better treatments and a cure.